FDA Clearance Tracker · K243306
Lancet (IA, IB, IC, ID, IE, IK, IL, IM, IIA, IIB, III, V, VI, VII, VIII, IX); Lancing device (HH-X-T, HH-XV-T, HH-XVI-T, HH-XVII-T, HH-XVIII-T, HH-XIX, HH-XXI-T, HH-XXII-T, HH-XXIII-T, HH-XXIV-T, HH-XXV-T, HH-XXVI-T, HH-XXVIII-T, HH-XXIX-T, HH-XXX-T, HH-XIII-T, HH-XXVII-T)
Last checked: Nov 19, 2026Latest source record: Nov 15, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Nov 15, 2024
Substantially Equivalent
Time to decision
25 days
Received Oct 21, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K243306
- Device name
- Lancet (IA, IB, IC, ID, IE, IK, IL, IM, IIA, IIB, III, V, VI, VII, VIII, IX); Lancing device (HH-X-T, HH-XV-T, HH-XVI-T, HH-XVII-T, HH-XVIII-T, HH-XIX, HH-XXI-T, HH-XXII-T, HH-XXIII-T, HH-XXIV-T, HH-XXV-T, HH-XXVI-T, HH-XXVIII-T, HH-XXIX-T, HH-XXX-T, HH-XIII-T, HH-XXVII-T)
- Applicant
- Tianjin Huahong Technology Co., Ltd.
- Applicant location
- Tianjin, CN
- Received
- Oct 21, 2024
- Decided
- Nov 15, 2024
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device class
- Class II
- Regulation
- 21 CFR 878.4850
- Specialty
- General & Plastic Surgery
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code QRL. The earliest in FDA's data is K214022, decided Feb 17, 2022.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K243306
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Tianjin Huahong Technology Co., Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Safety lancet (XL)510(k)
K262526 · Decided Sep 13, 2026 · 53 days after receipt
Device type: Single Use Only Blood Lancet With An Integral Sharps Injury Prevention Feature (FMK) · General & Plastic Surgery
- Lancing device510(k)
K262135 · Decided Aug 18, 2026 · 54 days after receipt
Device type: Multiple Use Blood Lancet For Single Patient Use Only (QRL) · General & Plastic Surgery
K260845 · Decided Aug 5, 2026 · 142 days after receipt
Device type: Container, Sharps (MMK) · Hospital Medicine & Nursing
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.